Lovegra

Lovegra in the UK – Female Sildenafil Safety Facts

Lovegra is a product commonly marketed online as a female version of sildenafil, the active ingredient used in regulated erectile dysfunction (ED) medicines for men. In the UK, sildenafil is a prescription-only medicine, and products such as Lovegra are not licensed by UK regulatory authorities.

This page is for educational purposes only, explaining how sildenafil works in the body, what is known about its use in women, and why medical oversight is essential.

---

What Is Lovegra?

Lovegra is marketed as containing sildenafil citrate, a PDE5 inhibitor. Sildenafil works by:

• Increasing blood flow through blood vessel relaxation

• Affecting circulation in genital tissues

• Acting only on blood flow, not sexual desire or hormones

While sildenafil is well studied in men, its effectiveness and safety in women are not clearly established, and it is not approved in the UK for female sexual dysfunction.

---

Key Facts About Sildenafil Use in Women

Important points to understand:

• Sildenafil is not licensed in the UK for women

• Evidence for benefit in female sexual dysfunction is limited and inconsistent

• It does not treat psychological, hormonal, or relationship factors

• Use without medical guidance may increase health risks

Female sexual health concerns often require individualised medical assessment rather than one-size-fits-all medication.

---

Safety Risks of Unlicensed Products

Unlicensed products such as Lovegra may:

• Contain incorrect or inconsistent dosages

• Include undisclosed ingredients

• Bypass UK quality and safety controls

• Increase the risk of side effects or interactions

Potential sildenafil side effects can include headache, flushing, dizziness, nausea, low blood pressure, and visual disturbances.